Unknown

Dataset Information

0

Microglial complement receptor 3 regulates brain Aβ levels through secreted proteolytic activity.


ABSTRACT: Recent genetic evidence supports a link between microglia and the complement system in Alzheimer's disease (AD). In this study, we uncovered a novel role for the microglial complement receptor 3 (CR3) in the regulation of soluble β-amyloid (Aβ) clearance independent of phagocytosis. Unexpectedly, ablation of CR3 in human amyloid precursor protein-transgenic mice results in decreased, rather than increased, Aβ accumulation. In line with these findings, cultured microglia lacking CR3 are more efficient than wild-type cells at degrading extracellular Aβ by secreting enzymatic factors, including tissue plasminogen activator. Furthermore, a small molecule modulator of CR3 reduces soluble Aβ levels and Aβ half-life in brain interstitial fluid (ISF), as measured by in vivo microdialysis. These results suggest that CR3 limits Aβ clearance from the ISF, illustrating a novel role for CR3 and microglia in brain Aβ metabolism and defining a potential new therapeutic target in AD.

SUBMITTER: Czirr E 

PROVIDER: S-EPMC5379986 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC6717897 | biostudies-other
| S-EPMC7561136 | biostudies-literature
2014-04-25 | GSE55627 | GEO
| S-EPMC1948958 | biostudies-literature
2024-02-29 | GSE255034 | GEO
| S-EPMC6492702 | biostudies-literature
| S-EPMC8892702 | biostudies-literature
| S-EPMC2988800 | biostudies-other
| S-EPMC7789385 | biostudies-literature
| S-EPMC10996762 | biostudies-literature